Research
Pipeline for Usher Syndrome Research (PUSH)
The Pipeline for Usher Syndrome Research (PUSH) at Boston Children’s Hospital will bring together six world-class scientists dedicated to accelerating the development of treatments for Usher Syndrome (USH). PUSH aims to tackle multiple forms of Usher Syndrome in parallel, identifying subtypes and mutations that may be amenable to innovative therapies. By advancing potential therapies over the next three years, PUSH will strive to identify optimized strategies that can move toward clinical trials, ultimately improving treatment options for hearing and vision loss associated with USH.
OUR WORLD CLASS SCIENTISTS LEADING PUSH RESEARCH
While there are several labs pursuing USH therapies around the world, here we have a unique opportunity because the six investigators are all leaders in their fields, are all located in one academic institution, and they all possess complementary expertise.
Why Your Support Matters:
Your donations will be crucial to launching this groundbreaking program. By supporting PUSH, you will:
- Help identify treatable forms of USH and advance targeted therapies.
- Support the development of various therapeutic approaches, such as gene replacement, antisense oligonucleotides (ASOs), genome editing, small molecules, and others.
- Propel research toward clinical trials that could one day restore hearing and vision for those affected by USH.

Be Part of a Life-Changing Initiative:
By contributing to PUSH, you will be part of an initiative that accelerates the search for effective therapies. While not all forms of USH may have an immediate treatment, this program will significantly advance the knowledge and strategies needed to identify and treat those that can be helped.
Your donation to PUSH will help transform lives by supporting research that has the potential to stop, and possibly even restore, hearing and vision loss. Every contribution brings us closer to breakthrough treatments, offering hope and real change for the future.